Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients
2015
Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
54
References
23
Citations
NaN
KQI